TerminatedNCT04507204

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

This study has public registry information. It focuses on ADHD and currently lists study information in the United States.

ADHDOtherOver 12 Years

In plain English

Key information made simple

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care. For people living with ADHD, being understood earlier and more clearly can shape the whole care journey. If the findings are useful, they could lead to earlier recognition and more informed decisions later on. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a university, with sites including Harmonex, Inc in Dothan, Southern California Research LLC in Beverly Hills, and CT Clinical Research in Cromwell. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually matching the main diagnosis and having a stable enough treatment background for the study, while common reasons not to take part include pregnancy or breastfeeding and safety concerns that need urgent care first. This is a later-stage study, which usually means the approach is being followed in broader real-world use.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Need help deciding?

Ask HopeStage to review this study with me

This form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.

Study reference: NCT04507204. We only ask for your email here. HopeStage can help you review the study, but this is not a medical eligibility decision.

In practice

For you

Taking part may help improve understanding of your condition.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in United States.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

Study clarity

Things to check before joining

Sponsor: Purdue Pharma LP
Sponsor type: Pharmaceutical company
Main activity: unknown
Time commitment: long follow-up or multiple visits
Study phase: Not available
Enrollment: Not available
Recruitment status: Terminated
Source: Official registry link

FAQ

Questions about this study

What is Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)?

This study is exploring a mental health research question for people with adhd. The research team can explain what participation involves. Direct benefit is not guaranteed.

Who is behind this study, and what type of sponsor is it?

This study is sponsored by Purdue Pharma LP. Based on the sponsor name or official registry information, it appears to be a pharmaceutical company. You should verify the details in the official registry record.

What does participation involve, what phase is it, and what should I ask about safety?

This study may involve unknown, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.

Where can I verify the study details?

Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.